These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7942361)

  • 1. [Morphometric study of low compliant bladder].
    Ohnishi N; Kishima Y; Hashimoto K; Kiwamoto H; Esa A; Sugiyama T; Park YC; Kurita T
    Hinyokika Kiyo; 1994 Aug; 40(8):657-61. PubMed ID: 7942361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new method of measurement of the urinary bladder blood flow in patients with low compliant bladder].
    Ohnishi N; Kishima Y; Hashimoto K; Kiwamoto H; Esa A; Sugiyama T; Park YC; Kurita T
    Hinyokika Kiyo; 1994 Aug; 40(8):663-7. PubMed ID: 7942362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of collagens in bladder fibrosis.
    Deveaud CM; Macarak EJ; Kucich U; Ewalt DH; Abrams WR; Howard PS
    J Urol; 1998 Oct; 160(4):1518-27. PubMed ID: 9751406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phenotypic changes in human bladder smooth muscle cell].
    Matsumoto S; Hanai T; Kurita T; Akiyama T
    Hinyokika Kiyo; 2003 Dec; 49(12):715-9. PubMed ID: 14978953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of neurogenic bladder dysfunction. I. Methods of prospective ultrastructural study and overview of the findings.
    Elbadawi A; Resnick NM; Dörsam J; Yalla SV; Haferkamp A
    J Urol; 2003 Feb; 169(2):540-6. PubMed ID: 12544304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of neurogenic bladder dysfunction. II. Myogenic basis of detrusor hyperreflexia.
    Haferkamp A; Dörsam J; Resnick NM; Yalla SV; Elbadawi A
    J Urol; 2003 Feb; 169(2):547-54. PubMed ID: 12544305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detrusor quantitative morphometry in obstructed males and controls.
    Collado A; Batista E; Gelabert-Más A; Corominas JM; Arañó P; Villavicencio H
    J Urol; 2006 Dec; 176(6 Pt 1):2722-8. PubMed ID: 17085203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of neurogenic bladder dysfunction. III. Intrinsic detrusor innervation.
    Haferkamp A; Dörsam J; Resnick NM; Yalla SV; Elbadawi A
    J Urol; 2003 Feb; 169(2):555-62. PubMed ID: 12544306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic features in the urinary bladder wall affected from neurogenic overactivity--a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A.
    Compérat E; Reitz A; Delcourt A; Capron F; Denys P; Chartier-Kastler E
    Eur Urol; 2006 Nov; 50(5):1058-64. PubMed ID: 16517054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxant effects of isoproterenol and selective beta3-adrenoceptor agonists on normal, low compliant and hyperreflexic human bladders.
    Igawa Y; Yamazaki Y; Takeda H; Kaidoh K; Akahane M; Ajisawa Y; Yoneyama T; Nishizawa O; Andersson KE
    J Urol; 2001 Jan; 165(1):240-4. PubMed ID: 11125417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of elasticity in dysfunctional bladders: urodynamic and histochemical correlation.
    Landau EH; Jayanthi VR; Churchill BM; Shapiro E; Gilmour RF; Khoury AE; Macarak EJ; McLorie GA; Steckler RE; Kogan BA
    J Urol; 1994 Aug; 152(2 Pt 2):702-5. PubMed ID: 8021999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative morphometric study of bladder detrusor between patients with benign prostatic hyperplasia and controls.
    Inui E; Ochiai A; Naya Y; Ukimura O; Kojima M
    J Urol; 1999 Mar; 161(3):827-30. PubMed ID: 10022694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type III collagen messenger RNA is modulated in non-compliant human bladder tissue.
    Kaplan EP; Richier JC; Howard PS; Ewalt DH; Lin VK
    J Urol; 1997 Jun; 157(6):2366-9. PubMed ID: 9146672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerosis-induced chronic ischemia causes bladder fibrosis and non-compliance in the rabbit.
    Azadzoi KM; Tarcan T; Siroky MB; Krane RJ
    J Urol; 1999 May; 161(5):1626-35. PubMed ID: 10210430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of bladder smooth muscle orientation in normal and spinal cord injured rats.
    Nagatomi J; Toosi KK; Grashow JS; Chancellor MB; Sacks MS
    Ann Biomed Eng; 2005 Aug; 33(8):1078-89. PubMed ID: 16133916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Video-urodynamic studies on 1800 patients with neurogenic bladder].
    JU YH; LIAO LM; LI D; FU G; LIANG WL; XIONG ZS; WU J; SHI WB; HAN CS
    Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(20):1525-8. PubMed ID: 19094643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Postoperative vesicourethral neurogenic dysfunction: the conceptual and clinical aspects based on the analysis of a series of 152 patients].
    Esteban Fuertes M; Salinas Casado J; Resel Estévez L; Sánchez Chapado M
    Arch Esp Urol; 1998 Nov; 51(9):901-16. PubMed ID: 9887564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new method for assessing sphincter resistance, in patients with low compliant bladder].
    López Pereira P; Martínez Urrutia MJ; Jaureguizar E
    Actas Urol Esp; 1996 Mar; 20(3):274-9. PubMed ID: 8712045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions.
    Klaphajone J; Kitisomprayoonkul W; Sriplakit S
    Arch Phys Med Rehabil; 2005 Nov; 86(11):2114-8. PubMed ID: 16271557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell chymase is a possible mediator of neurogenic bladder fibrosis.
    Howard PS; Renfrow D; Schechter NM; Kucich U
    Neurourol Urodyn; 2004; 23(4):374-82. PubMed ID: 15227657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.